Atlas Trials

A Study to Determine if New Types of Malaria Vaccines Are Safe, Effective and Lead to Immunity in Kenyan Adults

Clinical trial NCT03947190 · TERMINATED

Trial details

NCT number
NCT03947190
Sponsor
University of Oxford
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Malaria,Falciparum
Start date
2022-08-31
Primary completion
2023-02-26
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.